دورية أكاديمية
Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment with Radioactive Iodine (I-131)
| العنوان: | Differentiated Thyroid Cancer in Pediatric Population (≤18 Years): Postoperative Treatment with Radioactive Iodine (I-131) |
|---|---|
| المؤلفون: | Marin Prpić, Maja Franceschi, Tomislav Jukić, Davor Kust, Nina Dabelić, Tea Varjačić, Marko Lucijanić, Ante Bolanča, Zvonko Kusić |
| المصدر: | Acta Clinica Croatica, Vol 58., Iss 1., Pp 119-126 (2019) |
| بيانات النشر: | Sestre Milosrdnice University hospital, Institute of Clinical Medical Research, 2019. |
| سنة النشر: | 2019 |
| المجموعة: | LCC:Medicine |
| مصطلحات موضوعية: | Iodine, Thyroid cancer, papillary, Adenocarcinoma, follicular, Survival rate, Child, Follow-up studies, Medicine |
| الوصف: | The aim is to present data on the treatment and follow-up in a cohort of patients with pediatric thyroid cancer who underwent total thyroidectomy and received postoperative radioactive iodine (I-131) therapy. The study was conducted in a tertiary high-volume thyroid center, in pediatric patients with differentiated thyroid cancer who were consecutively treated during the 1965-2015 period. A total of 45 patients aged ≤18 years having undergone total thyroidectomy with or without selective neck dissection were included in the study. Decision on postoperative I-131 ablation was based on tumor characteristics, postoperative thyroglobulin level, preablative whole body scintigraphy, and/or neck ultrasound. Median age at diagnosis was 15 years. The presence of cervical lymph node metastases was significantly associated with papillary thyroid cancer, larger tumor size, involvement of two thyroid lobes, and multifocal disease. The presence of distant metastases was significantly associated with larger tumor size. None of the patients died during follow-up period, and the 5-year and 10-year overall survival rates were 100%. The 5-year and 10-year progression-free survival (PFS) rates were 87% and 73%, respectively. Male gender (p=0.046), age ≤15 years (p=0.029) and tumor size >15 mm (p=0.042) were significantly associated with inferior PFS. A significant positive trend of increase in the number of newly diagnosed patients was observed over time (p=0.011). Clinical management of pediatric thyroid cancer is challenging, especially in the light of increasing incidence in this population. Male patients younger than 15 years and with tumors of more than 15 mm in size require additional caution due to lower PFS observed. |
| نوع الوثيقة: | article |
| وصف الملف: | electronic resource |
| اللغة: | English |
| تدمد: | 0353-9466 1333-9451 |
| Relation: | https://hrcak.srce.hr/file/322463; https://doaj.org/toc/0353-9466; https://doaj.org/toc/1333-9451 |
| DOI: | 10.20471/acc.2019.58.01.16 |
| URL الوصول: | https://doaj.org/article/773266c01a6d4057a7f0dc6611cfc7b3 |
| رقم الأكسشن: | edsdoj.773266c01a6d4057a7f0dc6611cfc7b3 |
| قاعدة البيانات: | Directory of Open Access Journals |
Full Text Finder | تدمد: | 03539466 13339451 |
|---|---|
| DOI: | 10.20471/acc.2019.58.01.16 |